C D Marsden, J D Parkes, J E Rees. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Dihydroxyphenylalanine/therapeutic useDrug EvaluationDrug Therapy, CombinationHumansParkinson Disease/complicationsParkinson Disease/drug therapyPlacebosPropranolol/administration & dosagePropranolol/therapeutic useTremor/complicationsTremor/drug therapy
Substances： See more » PlacebosDihydroxyphenylalaninePropranolol
Year: 1974 PMID： 4136980 DOI： 10.1016/s0140-6736(74)91794-2
Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321